- Australian Prescription Products Guide
SummaryCMPMedica Australia Pty Ltd's proposed acquisition of the Australian Prescription Products Guide.
Market definitionThe proposed acquisition was considered in the context of the national market for the publication and supply of drug information publications, within which exists a segment for publications including Product Information (PI) and Consumer Medicines Information (CMI).
Competition analysisOn 10 October 2007 the ACCC formed the view that the proposed acquisition was unlikely to result in a substantial lessening in competition in the relevant market. Factors informing this decision include:
- other drug information publications containing generic drug monographs (in particular AusDI) would be close, but not perfect, substitutes to the products of the merged firm; and
- there are existing suppliers of drug information publications in Australia that would have the ability to expand their current product offering to include PI and CMI (with equivalent functionality to the MIMS and the Australian Prescription Products Guide products) for a relatively low cost and time investment.
|08/08/2007||ACCC commenced review under the Merger Review Process Guidelines. Market inquiries commence.|
|22/08/2007||Closing date for submissions from interested parties.|
|23/08/2007||ACCC requested further information from CMPMedica. ACCC timeline suspended.|
|28/08/2007||Former proposed date of 5 September 2007 for announcement of ACCC's findings, amended to allow CMPMedica to provide further information.|
|19/09/2007||ACCC received further information from CMPMedica. ACCC timeline recommenced.|
|10/10/2007||ACCC announced it would not oppose the proposed acquisition.|